ATTO Stock Summary and Trading Ideas (Attovia Therapeutics | NASDAQ:ATTO)

Attovia Therapeutics Inc is a clinical stage biotechnology company focused on research and development of therapeutic products in the fields of immune-mediated diseases. Its product pipeline includes ATTO-1310 and ATTO-2306 for immune-dermatology indications and ATTO-1091 for inflammatory diseases, including inflammatory bowel disease (IBD). The company's product candidates are developed using its ATTOBODY biologics platform.

What symbol and exchange does Attovia Therapeutics shares trade?

Attovia Therapeutics trades on the NASDAQ stock market under the symbol ATTO.

What is Attovia Therapeutics stock price doing today?

As of October 2, 2026, ATTO stock price declined to $17.17 with 329,004 million shares trading.

How much is Attovia Therapeutics worth?

ATTO has a market cap of $783.83 million. This is considered a Small Cap stock.

What are the top ETFs holding Attovia Therapeutics?

The top ETF exchange traded funds that ATTO belongs to (by Net Assets): SCHA, VTI, VXF, VTWO, SCHB.

What are the support and resistance levels for Attovia Therapeutics (ATTO)?

ATTO support price is $16.53 and resistance is $19.05 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that ATTO shares will trade within this expected range on the day.